Literature DB >> 3144539

Fleroxacin: safety, tolerance and effect on the faecal flora of healthy volunteers.

P M Shah1, A Sammann, V Schäfer, M Seczendi, H Knothe.   

Abstract

The safety, tolerance, and influence on the faecal flora of volunteers of fleroxacin was studied following a daily dose of 800 mg for seven days. A major reduction was seen in the numbers of Escherichia coli, but there was no change in anaerobic bacteria or the faecal streptococci. Ophthalmological examinations and laboratory evaluations revealed no untoward effect. Reduced appetite and flatulence were observed in one volunteer each, two reported loose stools, and five complained of sleep disturbances. All volunteers completed the study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144539     DOI: 10.1093/jac/22.supplement_d.209

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  Fleroxacin clinical pharmacokinetics.

Authors:  A E Stuck; D K Kim; F J Frey
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 2.  Clinical features and management of adverse effects of quinolone antibacterials.

Authors:  J H Paton; D S Reeves
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

3.  Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.

Authors:  W R Bowie; V Willetts; P J Jewesson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 4.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 5.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

Review 6.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.